Acutus Medical, Inc. AFIB OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score

45/100

2/7 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Acutus Medical, Inc. (AFIB) .

本页证实的标准:

VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+499900%).
分析师共识目标价 $1.50 (+499900% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分： 45/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score

45/100

SG Score

View full scorecard →

✓

价值

100/100

Price-to-Earnings & upside

Proven by this page

未來

52/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

健康

50/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

15/100

→ Income

✓

成长

90/100

→ Income

✗

收入

10/100

→ Income

估值概览 — AFIB

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.32

每股账面价值$0.00

每股营收$0.68

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

分析师目标价$1.50 (+499900%)

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2018	$-1.75	$2.17M	$-47.91M	-2211.8%
2019	$-3.54	$2.84M	$-119.31M	-4206.9%
2020	$-8.94	$8.46M	$-101.98M	-1204.9%
2021	$-4.11	$17.26M	$-123.36M	-714.6%
2022	$-1.39	$16.36M	$-39.62M	-242.1%
2023	$-2.81	$7.16M	$-81.66M	-1139.9%
2024	$-0.32	$20.16M	$-9.55M	-47.4%